» Articles » PMID: 36410798

Development and Evaluation of a Psychosocial Adaptation Questionnaire for Women with Breast Cancer Treated with Adjuvant Endocrine Therapy: a Single-centre, Cross-sectional Study in China

Overview
Journal BMJ Open
Specialty General Medicine
Date 2022 Nov 21
PMID 36410798
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To develop and evaluate a psychosocial adaptation (PSA) questionnaire of women with breast cancer treated with adjuvant endocrine therapy (AET).

Design: Cross-sectional study.

Setting: Conducted study in a tertiary care centre in China from March to June 2021.

Participants: Women with breast cancer who have received AET.

Methods: Item development and extraction were based on literature, qualitative interviews (n=16) and assessment of content validity. 300 participants were recruited to perform item analysis, internal consistency reliability and exploratory factor analysis by cross-sectional studies. Finally, test-retest, criterion validity and confirmatory factor analysis of the questionnaire were performed with 96 respondents.

Results: An initial questionnaire was devised. The exploratory factor analysis demonstrated four factors: emotional response (six items), self-worth (five items), physical impacts (three items) and social communication (two items). The cumulative contribution of the factors was 65.057%. Cronbach's alpha coefficient of the questionnaire was 0.876. The correlation coefficient between the questionnaire and General Self-Efficacy Scale was 0.565 (p<0.01). A 16-item questionnaire and its factorial structure were confirmed.

Conclusions: The 16-item questionnaire had good reliability and validity. This could be a useful tool to assess the PSA levels among women with breast cancer treated with AET and provide a basis for further research.

References
1.
Kolokotroni P, Anagnostopoulos F, Missitzis I . Psychosocial Adjustment to Illness Scale: Factor structure, reliability, and validity assessment in a sample of Greek breast cancer patients. Women Health. 2016; 57(6):705-722. DOI: 10.1080/03630242.2016.1186780. View

2.
Pagani O, Francis P, Fleming G, Walley B, Viale G, Colleoni M . Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT. J Clin Oncol. 2019; 38(12):1293-1303. PMC: 7164485. DOI: 10.1200/JCO.18.01967. View

3.
Cronbach L, WARRINGTON W . Time-limit tests: estimating their reliability and degree of speeding. Psychometrika. 1951; 16(2):167-88. DOI: 10.1007/BF02289113. View

4.
Mystakidou K, Parpa E, Tsilika E, Galanos A, Vlahos L . General perceived self-efficacy: validation analysis in Greek cancer patients. Support Care Cancer. 2008; 16(12):1317-22. DOI: 10.1007/s00520-008-0443-z. View

5.
Wang X, Zhao T, Zhang X . [Assessment on the reliability and validity of the Dermatology Life Quality Index in Chinese version]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004; 25(9):791-3. View